Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04040348 · ClinicalTrials.gov registry record · Phase 1

Alzheimer's Disease Stem Cells Multiple Infusions

A Phase 1 study of Alzheimer Disease, sponsored by Bernard (Barry) Baumel.

Completed
Registry status
Phase 1
Development phase
6
Enrollment target
1
Study location

NCT04040348 is a Phase 1 study of Alzheimer Disease that has completed, run by Bernard (Barry) Baumel. The registered enrollment target is 6 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04040348, a Phase 1 study of Alzheimer Disease, has completed, sponsored by Bernard (Barry) Baumel.

COMPLETED
Registry status
Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

Conditions Studied

Alzheimer Disease

Interventions

  • BIOLOGICAL Approximately 100 million cells allogeneic hMSC

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-10-08
Est. Completion 2023-04-25
Phase Phase 1

Sponsor

Bernard (Barry) Baumel

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04040348

The ClinicalTrials.gov registry entry for NCT04040348 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is Bernard (Barry) Baumel, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Approximately 100 million cells allogeneic hMSC is the first listed.

NCT04040348 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04040348 about?

NCT04040348 is a clinical study titled "Alzheimer's Disease Stem Cells Multiple Infusions". The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

What is the current status of trial NCT04040348?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-10-08. Estimated completion is 2023-04-25.

What conditions does trial NCT04040348 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT04040348?

The interventions under investigation include: Approximately 100 million cells allogeneic hMSC (BIOLOGICAL).

Who is sponsoring clinical trial NCT04040348?

This trial is sponsored by Bernard (Barry) Baumel, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04040348 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.